SHORT DESCRIPTION
For cardiac care providers, this novel system integrates wireless, body-integrated devices to provide autonomous, temporary electrotherapy. It improves patient mobility while reducing healthcare risks and costs. BACKGROUND
Patients recovering from cardiac surgery face significant challenges with existing temporary pacing solutions. Traditional systems rely on wired hardware and external modules that restrict mobility and elevate infection risks. These methods often require invasive procedures, extend hospital stays, and increase treatment costs. There is a clear need for a less invasive, wire-free solution that addresses these limitations. ABSTRACT
This invention presents a transient closed-loop network of wireless, body-integrated devices designed for temporary cardiac electrotherapy. The system synchronizes sensor data and delivers timely, battery-free stimulation via a bioresorbable pacemaker. In addition, skin-interfaced modules provide haptic feedback to support patient care in both hospital and home settings. Early validation in simulated clinical environments demonstrates its potential to safely bridge patient therapy until permanent devices are considered. MARKET OPPORTUNITY
The global market for temporary pacemakers was valued at approximately $580 million in 2024 and is projected to reach $1.1 billion by 2034, expanding at a CAGR of 6.5% (Source: Reports and Data, 2024). This market is a critical component of the broader $20.77 billion cardiac rhythm management (CRM) device industry (Source: Grand View Research, 2024). DEVELOPMENT STAGE
TRL-5 Prototype Validated in Relevant Environment: The prototype integrates sensor, stimulation, and feedback modules, and has been successfully tested in a simulated clinical setting. APPLICATIONS
IP STATUS
US Patent Application US18/845,029 Pending (View Patent Details)